Emerging cardiometabolic complications of androgen deprivation therapy
Authors:
- 12 February 2010
- journal article
- review article
- Published by Taylor & Francis in The Aging Male
- Vol. 13 (1) , 1-9
Abstract
Prostate cancer (PCa) is the most common malignancy in men. Androgen deprivation therapy (ADT) is used in the treatment of locally advanced and metastatic PCa. Although its use has improved survival in a subset of patients, it also has negative consequences. Osteoporosis, sexual dysfunction, hot flashes and adverse changes in body composition are well-known and well-studied complications of ADT. Recent studies have also found metabolic complications in these men such as insulin resistance, diabetes and metabolic syndrome. In addition, these men might also experience higher cardiovascular mortality. Studies are needed to determine the mechanism behind these complications and to employ strategies to prevent them.Keywords
This publication has 59 references indexed in Scilit:
- The Dark Side of Testosterone Deficiency: III. Cardiovascular DiseaseJournal of Andrology, 2009
- Low Serum Testosterone and Mortality in Older MenThe Journal of Clinical Endocrinology & Metabolism, 2008
- Androgen deficiency, diabetes, and the metabolic syndrome in menCurrent Opinion in Endocrinology, Diabetes and Obesity, 2007
- Increasing use of gonadotropin‐releasing hormone agonists for the treatment of localized prostate carcinomaCancer, 2005
- 6-Month Androgen Suppression Plus Radiation Therapy vs Radiation Therapy Alone for Patients With Clinically Localized Prostate CancerJAMA, 2004
- Critical evaluation of hormonal therapy for carcinoma of the prostateUrology, 2002
- Testosterone Replacement and Resistance Exercise in HIV-Infected Men With Weight Loss and Low Testosterone LevelsJAMA, 2000
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941